Literature DB >> 28396542

Ethambutol Is Cleared by a Contemporary High-Flux Hemodialyzer, and Drug Monitoring Ensures Safety and Therapeutic Effect.

Rusheng Chew1,2, Sarah Jongbloed3, Dev Jegatheesan4, Helen Healy2,4, Kim Ta5, Jacobus Ungerer6, Brett McWhinney6, Peter Donovan2,7, Marion L Woods1,2.   

Abstract

It is uncertain, given the lack of recent data and the inconclusive nature of previous data, whether ethambutol is cleared by hemodialysis using contemporary dialyzers. We measured serum ethambutol concentrations before, during, and 1 h after hemodialysis in a 75-year-old Caucasian man receiving ethambutol for disseminated Bacille Calmette-Guérin infection. There was a mean 41% decrease in serum ethambutol concentration during dialysis, confirming the hemodialyzability of ethambutol and the utility of drug monitoring in ensuring safety.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  drug monitoring; ethambutol; hemodialysis

Mesh:

Substances:

Year:  2017        PMID: 28396542      PMCID: PMC5444158          DOI: 10.1128/AAC.01988-16

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis.

Authors:  Henry M Blumberg; William J Burman; Richard E Chaisson; Charles L Daley; Sue C Etkind; Lloyd N Friedman; Paula Fujiwara; Malgosia Grzemska; Philip C Hopewell; Michael D Iseman; Robert M Jasmer; Venkatarama Koppaka; Richard I Menzies; Richard J O'Brien; Randall R Reves; Lee B Reichman; Patricia M Simone; Jeffrey R Starke; Andrew A Vernon
Journal:  Am J Respir Crit Care Med       Date:  2003-02-15       Impact factor: 21.405

2.  The effect of hemodialysis on isoniazid, rifampin, pyrazinamide, and ethambutol.

Authors:  R S Malone; D N Fish; D M Spiegel; J M Childs; C A Peloquin
Journal:  Am J Respir Crit Care Med       Date:  1999-05       Impact factor: 21.405

3.  Clinical pharmacology of ethambutol.

Authors:  V A PLACE; J P THOMAS
Journal:  Am Rev Respir Dis       Date:  1963-06

Review 4.  Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease.

Authors:  Heather Milburn; Neil Ashman; Peter Davies; Sarah Doffman; Francis Drobniewski; Saye Khoo; Peter Ormerod; Marlies Ostermann; Catherine Snelson
Journal:  Thorax       Date:  2010-06       Impact factor: 9.139

5.  Susceptibility of Mycobacterium bovis BCG vaccine strains to antituberculous antibiotics.

Authors:  Nicole Ritz; Marc Tebruegge; Tom G Connell; Aina Sievers; Roy Robins-Browne; Nigel Curtis
Journal:  Antimicrob Agents Chemother       Date:  2008-10-27       Impact factor: 5.191

Review 6.  Therapeutic drug monitoring in the treatment of tuberculosis: an update.

Authors:  Abdullah Alsultan; Charles A Peloquin
Journal:  Drugs       Date:  2014-06       Impact factor: 9.546

7.  The ocular toxicity of ethambutol and its relation to dose.

Authors:  J E Leibold
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

8.  Ethambutol-induced ocular toxicity revisited.

Authors:  K L Alvarez; L C Krop
Journal:  Ann Pharmacother       Date:  1993-01       Impact factor: 3.154

9.  Ethambutol optimal clinical dose and susceptibility breakpoint identification by use of a novel pharmacokinetic-pharmacodynamic model of disseminated intracellular Mycobacterium avium.

Authors:  Devyani Deshpande; Shashikant Srivastava; Claudia Meek; Richard Leff; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2010-03-15       Impact factor: 5.191

Review 10.  Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure.

Authors:  Vincent Launay-Vacher; Hassane Izzedine; Gilbert Deray
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 5.577

View more
  1 in total

1.  Ethambutol and isoniazid induced severe neurotoxicity in a patient undergoing continuous ambulatory peritoneal dialysis.

Authors:  Meijun Si; Huiqun Li; Yanru Chen; Hui Peng
Journal:  BMJ Case Rep       Date:  2018-05-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.